ATLANTA, GA and BERLIN, Germany - (
NewMediaWire ) - September 26, 2023 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, and ProBioGen announce the signing of a landmark commercial license agreement for ProBi